PMID: 8938259Feb 9, 1996Paper

Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study

Neuroscience Letters
E L HelkalaP Riekkinen

Abstract

The apolipoprotein E epsilon4 allele is the most common risk factor for Alzheimer's disease (AD). The epsilon2 allele may play a protective role in AD. Our previous cross-sectional study showed that in non-demented elderly subjects the epsilon2 allele is associated with better learning ability than other alleles. We wished to investigate the influence of different apolipoprotein E (apoE) phenotypes on cognitive functions in a 3-year follow-up study starting with a random sample of 917 non demented elderly subjects. Episodic memory was examined with the List Learning Test (Buschke's selective reminding method), as well as with immediate and delayed recall of figures. Retrieval from semantic memory was assessed with the Category and Verbal Fluency tests. Constructional abilities were examined by copying figures. Attention functions were examined with the Trail Making A and B tests. A total of 632 subjects completed the 3-year follow-up study. The subjects with apoE phenotypes E2/2 or E2/3 were able to maintain their verbal learning performance, while the learning ability of the subjects with other apoE phenotypes deteriorated. We suggest that successful mental aging may be at least in part associated with genetic factors.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Dec 1, 1992·Psychology and Aging·D F HultschR A Dixon
Jul 10, 1987·Science·J W Rowe, R L Kahn
Oct 1, 1986·Pathology, Research and Practice·F C StamA W Smeulders
May 26, 1995·Neuroscience Letters·E L HelkalaP Riekkinen
Sep 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·J KuusistoM Laakso
Jul 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·J LouhijaR S Tilvis
Jan 1, 1994·Atherosclerosis·K KervinenY A Kesäniemi
Jan 15, 1993·The American Journal of Cardiology·J E EichnerJ D Neaton
Mar 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·W J StrittmatterA D Roses

❮ Previous
Next ❯

Citations

Jul 16, 2005·Social Psychiatry and Psychiatric Epidemiology·J H ZhaoS E Humphries
Jun 1, 1996·Trends in Neurosciences·H S Soininen, P J Riekkinen
Dec 10, 2002·Neuroscience and Biobehavioral Reviews·Lars-Göran NilssonLars Bäckman
Jun 18, 2002·Ageing Research Reviews·Jonathan D Smith
Aug 23, 2007·International Psychogeriatrics·Nicholas A KozauerConstantine G Lyketsos
May 19, 2004·Journal of the International Neuropsychological Society : JINS·James A LevyTrey Sunderland
Sep 12, 2006·Journal of the International Neuropsychological Society : JINS·Elizabeth W TwamleyMark W Bondi
Dec 9, 2004·Psychology and Aging·Brent J SmallLars Bäckman
Mar 21, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·E L HelkalaJ T Salonen
Feb 24, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·G B FrisoniM Trabucchi
Jul 23, 1999·Acta Neurologica Scandinavica·H B StaehelinW J Perrig
Dec 16, 1996·Annals of the New York Academy of Sciences·Y J KwonN R Relkin
Feb 18, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·L MosconiA Pupi
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·R S WilsonD A Bennett
Jan 1, 1997·Annual Review of Psychology·M Gallagher, P R Rapp
Aug 4, 2009·Future Lipidology·Elena Posse de Chaves, Vasanthy Narayanaswami
Oct 12, 2012·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Rune Lindahl-JacobsenLene Christiansen
Jan 18, 2005·Neurobiology of Aging·Jae Hee KangFrancine Grodstein
Jun 14, 2006·Journal of the Neurological Sciences·Alexander I TrösterWilliam C Koller
Nov 5, 2013·Neuroscience and Biobehavioral Reviews·Sana SuriClare E Mackay
Mar 5, 2016·Annals of Neurology·Mitsuru ShinoharaGuojun Bu
Mar 3, 1999·American Journal of Human Genetics·J M SilvermanK L Davis
Aug 6, 2011·Trends in Cognitive Sciences·Robert M BilderD Stott Parker
Jul 29, 2016·Frontiers in Human Neuroscience·Kyoko KonishiVéronique D Bohbot
Nov 30, 2000·Archives of Physiology and Biochemistry·C C JoyalR Lalonde
Nov 25, 2005·Journal of Geriatric Psychiatry and Neurology·Gary E SwanAsenath La Rue
Feb 11, 2009·American Journal of Alzheimer's Disease and Other Dementias·D V MorettiG B Frisoni
Dec 20, 2000·American Journal of Medical Genetics·J D FloryM F Muldoon
Feb 7, 2003·International Journal of Geriatric Psychiatry·Frances RiceJulie Williams
Jan 27, 1999·Annals of Medicine·H S Soininen, P Scheltens
Jun 9, 2020·Oxidative Medicine and Cellular Longevity·Abdullah Al MamunMohamed M Abdel-Daim
Mar 17, 2006·Journal of Neurogenetics·Anne M KoivistoHilkka Soininen
Nov 6, 2020·Molecular Neurodegeneration·Zonghua LiGuojun Bu
Nov 21, 2020·Journal of Alzheimer's Disease : JAD·Mengtian DuPaola Sebastiani
May 18, 2021·Frontiers in Aging Neuroscience·Xiaocao LiuUNKNOWN Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Aug 10, 2021·Journal of Alzheimer's Disease : JAD·Benjamin SweigartPaola Sebastiani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.